What are the factors that affect hospitalization and surgery for aggravation of ulcerative colitis?

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 3, 2014, Pages 282-287

  Matsumoto, Satohiro ^a   Yoshida, Yukio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Colectomy; Cytomegalovirus; Hospitalization; Thiopurine immunomodulators; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COLECTOMY; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS INFECTIONS; DRUG UTILIZATION; FEMALE; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; IMMUNOLOGIC FACTORS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84895073743     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000028     Document Type: Article

References (25)

1. Matsumoto T, Andoh A, Okawa K, Ito H, Torii A, Yoshikawa S, et al. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective openlabel study. Ther Apher Dial 2008; 12: 484-490.
2. Järnerot G, Rolny P, Sandberg-Gertzén H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985; 89: 1005-1013.
3. Turner D,Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a metaregression. Clin Gastroenterol Hepatol 2007; 5: 103-110.
4. Gustavsson A, Halfvarson J, Magnuson A, Sandberg-Gertzén H, Tysk C, Järnerot G. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol 2007; 102: 2513-2519.
5. The Research/Study Group regarding intractable inflammatory intestinal disorders. The guidelines for the treatment for ulcerative colitis. Fiscal year 2012 group study report. Tokyo: Ministry of Health, Labour andWelfare; 2013.
6. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012; 6: 965-990.
7. Riegler G, Tartaglione MT, CarratúR, D'IncáR, Valpiani D, Russo MI, et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci 2000; 45: 462-465.
8. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134: 929-936.
9. Criscuoli V, Casà A, Orlando A, Pecoraro G, Oliva L, Traina M, et al. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 2004; 36: 818-820.
10. Cottone M, Pietrosi G, Martorana G, Casà A, Pecoraro G, Oliva L, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96: 773-775.
11. Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004; 53: 1155-1160.
12. Ardizzone S, Maconi G, Russo A, Berthelot P, Del Tedesco E, Phelip JM, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006; 55: 47-53.
13. Timmer A, McDonald JW, Tsoulis DJ, Macdonald JK. Azathioprine and 6- mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2012; 9:CD000478.
14. Gisbert JP, Linares PM, McNicholl AG, MatéJ, Gomollón F. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Aliment Pharmacol Ther 2009; 30: 126-137.
15. Paoluzi OA, Pica R, Marcheggiano A, Crispino P, Iacopini F, Iannoni C, et al. Azathioprine or methotrexate in the treatment of patients with steroiddependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission. Aliment Pharmacol Ther 2002; 16: 1751-1759.
16. Mocciaro F, Renna S, Orlando A, Rizzuto G, Sinagra E, Orlando E, et al. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study. J Crohns Colitis 2012; 6: 681-686.
17. Chaparro M, Burgueño P, Iglesias E, Panés J, Muñoz F, Bastida G, et al. Infliximab salvage therapy after failure of ciclosporin in corticosteroidrefractory ulcerative colitis: a multicentre study. Aliment Pharmacol Ther 2012; 35: 275-283.
18. Barabino A, Torrente F, Castellano E, Gandullia P, Calvi A, Cucchiara S, et al. The use of ciclosporin in paediatric inflammatory bowel disease: an Italian experience. Aliment Pharmacol Ther 2002; 16: 1503-1507.
19. Castro M, Papadatou B, Ceriati E, Knafelz D, De Angelis P, Ferretti F, et al. Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis. Langenbecks Arch Surg 2007; 392: 161-164.
20. Bamba S, Tsujikawa T, Inatomi O, Nakahara T, Koizumi Y, Saitoh Y, et al. Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis. J Gastroenterol Hepatol 2010; 25: 494-498.
21. Leblanc S, Allez M, Seksik P, FlouriéB, Peeters H, Dupas JL, et al. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol 2011; 106: 771-777.
22. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 2002; 50: 485-489.
23. Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, et al. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Am J Gastroenterol 2009; 104: 2760-2767.
24. Lobel EZ, Korelitz BI, Xuereb MA, Panagopoulos G. A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis. Am J Gastroenterol 2004; 99: 462-465.
25. Hawthorne AB, Logan RF, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET, et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992; 305:20-22.